Your ICP Describes a Market. It Doesn't Describe a Buyer.

Ask a healthtech commercial leader who their ideal customer is. You will get an answer in about four seconds. Mid-size health systems. Regional payers with value-based care programs. Ambulatory groups with more than fifty providers.

Fast, confident, and useless the moment you try to act on it. Here is what that costs:

• 13%. The average MQL to SQL conversion rate in healthcare, weighed down by compliance hurdles and long approval chains.
• 35%. How much longer the buying cycle runs when multi-stakeholder approval is required. In healthcare, that is most deals.
• $500K. What revenue leaks from broken handoffs and poor routing can cost a B2B company annually.

Because that answer tells you the size of the market. It does not tell you which organizations inside it are ready to buy, why they are ready, or what has to be true for a conversation to go anywhere. Two health systems can be identical on bed count, revenue, region, and EMR, and be completely different on buying readiness. One has a CEO who made digital transformation a board-level priority eighteen months ago. The other has the same profile and is frozen in financial recovery. A firmographic filter puts them on the same list.

A situational ICP asks what has to be true. Not how big they are. What is on their strategic agenda: over 80% of providers saw their value-based care contracts grow recently, which is a specific, dateable trigger for anyone selling care coordination. What internal capacity exists: only about a third of providers rate their data integration as excellent, so if your product depends on integration, that third is your real market. An organization with a standing transformation office is structurally more ready than one starting from scratch.

The committee test is the last filter. Hospital procurement now routes through medical directors, heads of purchasing, and CFOs, with committees that routinely run six to ten people. If that alignment does not exist inside the account, the deal is not ready no matter what the firmographics say. A weak ICP sits underneath every other GTM problem. Marketing writes for an audience that is too wide. Sales works accounts that will not move this year. The leaks compound.

If you already have a target account list: do these three things this week

1. Pull your last ten closed-won deals and write one sentence each on the trigger. What made them start looking? A reimbursement change, a new contract, an executive hire, a failed vendor. If you cannot answer for more than half, that gap is your ICP.
2. Score your list on one situational criterion. Pick the strongest trigger you found in step one and sort the whole list by it. You will likely cut a third of the names, which is the point.
3. Rewrite the ICP so a rep can be wrong with it. The output should let someone look at a new account and make a clear judgment, not because of bed count, but because of what is happening inside it right now.

If you are building your first ICP: do these three instead

1. Start with the deals you lost to "no decision." They tell you more than your wins. Look for what was missing: budget authority, a mandate, an internal owner.
2. Write the three things that must be true. One about strategic agenda, one about internal capacity, one about the buying committee. Three lines total. Put it in the CRM as a required field.
3. Name the person who owns the definition. The ICP is not a marketing document. It is the commercial team's shared theory of who buys, why, and when. If nobody owns it, it drifts back to firmographics within a quarter.

The reframe

Time is the most constrained resource on any healthcare commercial team. Every hour spent on an account that will not convert in the next twelve months is an hour not spent on one that will.

The companies winning here are working a shorter, more accurate list and closing it at a rate that makes the math work.

A sharp ICP does not shrink your market. It shrinks your list.

And if you don't want to do it alone, let us know.

‍